> at least there will be lessons learned for the future development of vaccines and increased scrutiny in their manufacturing process. I’m nagging, but we’ve g

> at least there will be lessons learned for the future development of vaccines and increased scrutiny in their manufacturing process. I’m nagging, but we’ve gone to extraordinary lengths to set a precedent where pharmaceutical companies are relieved of the burden of demonstrating the safety of their products and also relieved of the risk of providing relief to anyone harmed by said products. 20 years later, emergency measures to protect Americans from terrorism are in effect today. I doubt Pfizer will be vulnerable to class-action suits ever again.